about
Severe Cushing's syndrome due to small cell prostate carcinoma: a case and review of literature.Body Image Disturbance in Acromegaly Patients Compared to Nonfunctioning Pituitary Adenoma Patients and Controls.Response to Radioiodine Therapy for Thyrotoxicosis: Disparate Outcomes for an Indigenous Population.Identification of Wnt family inhibitors: a pituitary tumor directed whole genome approach.Metastatic parathyroid carcinoma initially misdiagnosed as parathyroid adenoma: the role of parafibromin in increasing diagnostic accuracy.Pregnancy after definitive treatment for Graves' disease--does treatment choice influence outcome?Increased SSTR2A and SSTR3 expression in succinate dehydrogenase-deficient pheochromocytomas and paragangliomas.Paraganglioma in Pregnancy: A Case Series and Review of the Literature.Factitious Graves' Disease Due to Biotin Immunoassay Interference-A Case and Review of the Literature.Lymphocytic hypophysitis with associated thyroiditis in a man with aseptic meningitis.A low incidence of iodine-induced hyperthyroidism following administration of iodinated contrast in an iodine-deficient region.Case report: clues to the diagnosis of an unsuspected massive levothyroxine overdose.Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).Hypercalcaemia due to parathyroid carcinoma presenting in the third trimester of pregnancy.Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.An apparently sporadic paraganglioma with an SDHB gene germline mutation presenting at age 68 years.Hickam's dictum: Myasthenia Gravis presenting concurrently with Graves' disease.Absence of Myostatin Improves Cardiac Function Following Myocardial Infarction.A Duodenal SDH-Deficient Gastrointestinal Stromal Tumor in a Patient With a Germline SDHB Mutation.Treatment choice, satisfaction and quality of life in patients with Graves' disease.Anaemia and thyrotoxicosis: The need to look for an alternative cause.Increased Admissions Due to Cardiac Complications of Thyrotoxicosis in Māori.Adherence to adrenal incidentaloma guidelines is influenced by radiology report recommendations.Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancerInsulin autoimmune syndrome due to IgG kappa paraproteinThyrotoxic, hypokalaemic periodic paralysis: Polynesians, an ethnic group at riskInsulinoma localization using hepatic venous sampling with selective arterial calcium stimulation: should a fixed calcium dose be used?Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutationsRetrospective investigation of testosterone undecanoate depot for the long-term treatment of male hypogonadism in clinical practiceSymptoms and signs of acromegaly: an ongoing need to raise awareness among healthcare practitionersThyrotoxicosis in an Indigenous New Zealand Population - a Prospective Observational StudyInequitable Long-Term Outcomes for an Indigenous Population After Definitive Treatment of Patients With Graves Disease
P50
Q33904201-8D894735-85A3-468B-9622-C342B6E89413Q35675855-BB5F61B3-F804-482B-9F37-16DA361FFBF4Q37089242-A2F77C45-88E1-40C0-B4BB-3C488C6D027CQ37704679-0C43D987-4D72-4518-9F29-3505F1A20EB1Q37928742-36CE40ED-DBCB-4788-B3D8-7C72A8B19F47Q38191709-1453B03E-02D2-4AF7-8ED0-6660664A83DCQ38388495-2D94D193-723A-4C85-98CE-9F7DEAF93140Q38530333-B8A93674-75F9-4B58-9CF4-3BAFB3542486Q38881668-AC967C39-E5BB-4F33-84F8-0A29939B99A3Q40422217-FBF5F995-10C2-4F07-AE4B-0029EE591837Q40930393-444B86B8-57D7-4B04-9160-9AF6DFA5D96EQ41137986-F2320826-408C-479A-A9C8-04FF4F1D822CQ44113647-7B3FD2C1-69C6-440E-97E9-18F5428F01B8Q46325538-8700582F-42EF-408C-AC8A-BD32E3948FA3Q46827190-F194586B-4122-4C14-A082-CD30F56131FAQ46939617-EB5D4455-5320-4D80-AFAE-EC24AA7B052BQ47780095-3A4D218C-9F3F-4FC3-9EA9-B92945BC1D49Q50433061-68A5E7FE-5321-4F99-AE46-092005432C1DQ51092102-7E6A3F37-3CE4-45C6-93A3-6B6155FCA5A7Q52597192-025632FB-99E9-4967-AD14-74D13CB59D3BQ52642527-05796E4D-85A3-44FF-8C7D-D91BF382F276Q52675044-46AA2181-3A74-436A-B4A5-C658445C220AQ53058891-44341A0F-5341-4D87-928C-3EA76195E87BQ57423318-7FDC28B1-F803-4C14-B38A-306D7E69AD28Q75391692-0F6604D8-6BD1-447D-B8F7-2C313C310380Q80339913-8245B532-7929-41B9-B937-CBBA9233FACFQ81254455-76308925-D13F-4CB3-B2B3-2819E0C6056BQ81604809-9E541AEB-9AC4-4273-8D64-03F88713B921Q86849763-68AB0A6D-5042-4282-B63A-570F271A5F08Q88032492-F4D6E304-080D-4E46-B4CF-F24AEDC5451EQ90250480-7D6E12A7-8E1D-417D-88F8-D0515118C9D1Q91727599-EFB35E02-E313-4D3B-9AF1-783F096B4263
P50
description
researcher ORCID ID = 0000-0002-0748-2300
@en
wetenschapper
@nl
name
Marianne S Elston
@ast
Marianne S Elston
@en
Marianne S Elston
@es
Marianne S Elston
@nl
type
label
Marianne S Elston
@ast
Marianne S Elston
@en
Marianne S Elston
@es
Marianne S Elston
@nl
prefLabel
Marianne S Elston
@ast
Marianne S Elston
@en
Marianne S Elston
@es
Marianne S Elston
@nl
P1153
12647495000
P21
P31
P496
0000-0002-0748-2300